Hardware Podcasts

213 - From Generic Underdog to Billion‑Dollar Exit: How Usman Ahmed Built & Sold a Sterile Injectable Site

Let's Combinate · 12 Nov 2025 · 43m

What this episode covers

Usman Ahmed, former CEO of Nexus Pharmaceuticals and current CEO of Quetzal Therapeutics, explains how he built a sterile injectable manufacturing company from a family-run generics startup into a billion-dollar asset sold to Eli Lilly. He details the strategic selection of the generic drug isoproterenol, the challenges of sourcing API and building a commercial sales force, and the critical decision to invest in high-speed prefilled syringe and lyophilization capacity when competitors failed. Ahmed discusses his current focus on rare diseases at Quetzal, including an oral formulation for acute promyelocytic leukemia (APL) and a treatment for the brain-eating amoeba Naegleria fowleri, emphasizing the importance of team building and decision-making under uncertainty.

Most relevant to

companies scaling up and large enterprises

Topics

Mentioned

Companies
Nexus Pharmaceuticals, Quetzal Therapeutics, Eli Lilly, Hospira, Baxter, Fresenius Kabi, IQVIA, Pfizer, Glaxo, Sanofi, Valiant Pharmaceuticals, Optima, Bouchard Strobel, Noble Nordis, Cyros Pharmaceuticals, Merck, Bristol Myers, AstraZeneca
Products
isoproterenol, Iron Sucrose

Related episodes from other shows

Other shows on the same ground, closest first.

  • How I Built This · 47m

    Live Episode! RXBAR: Peter Rahal

    Peter Rahal, founder of RXBAR, and his co-founder Jared Smith explain how they launched a protein bar company in 2013 by targeting the CrossFit community with a minimal-ingredient product made in a Cuisinart. They bootstrapped the business with $10,000, selling directly to gyms and online, and eventually scaled to $36 million in sales before Kellogg's acquired RXBAR for $600 million in 2017. Rahal details the critical decision to dump $300,000–$400,000 worth of inventory due to shelf-life stability issues with an early co-packer, a move that preserved brand integrity despite causing a temporary stockout.

    Starting a product companyValidation & product-market fit
    8 chapters

  • Being an Engineer · 35m

    S1E02 $1k to $25M in 12 years | Dan Kasprzyk

    Dan Kasprzyk, CEO of Poba Medical and Symple Surgical and board member of Machine Solutions, recounts his journey from a bioengineering student at ASU to building Machine Solutions from $1,000 to $25 million in revenue over 12 years. He explains how his team developed a specialized crimping technology for balloon catheters, successfully selling to major medical device companies like Medtronic, Boston Scientific, and Johnson & Johnson by solving a critical manufacturing pain point that large internal teams could not address. Kasprzyk details the strategic decision to focus on this specific product-led growth, which allowed the company to scale to 100 employees and eventually attract private equity interest, leading to his current ventures in microwave ablation and testing equipment.

    Starting a product companyMechanical engineering
    6 chapters

  • Global Medical Device Podcast · 39m

    #455: MedTech Founder 101: Shifting from Corporate to Startup with John Schindler

    John Schindler, CEO of Liquet Medical, discusses the transition from corporate roles at Atrium and Merit Medical to founding a startup, emphasizing the 'novel but simple' philosophy for vascular drug delivery devices. He explains how Liquet leverages its 510(k) clearance for pulmonary embolism treatment while planning an IDE trial, advocating for limited market releases to build strategic enterprise value through intentional clinical data. Schindler also covers the challenges of fundraising, negotiating with regulatory service providers, and the importance of early FDA engagement to avoid timeline resets.

    Validation & product-market fitFundraising & investors
    9 chapters

  • Manufacturing Happy Hour · 36m

    Cosmetics, Contract Manufacturing, and Leading through Exponential Growth with Dynamic Blending’s Gavin Collier

    Gavin Collier, CEO of Dynamic Blending, explains how the Utah-based contract manufacturer achieved 11,300% growth in 2020 by offering a true turnkey service that includes R&D, graphic design, and logistics for cosmetics and oral care products. Collier details the company's evolution from an R&D consultancy to a full-scale manufacturer, highlighting the importance of serving underserved customers with small minimum order quantities. He attributes this success to a customer-centric culture, a high-quality team of former Fortune 500 executives, and a willingness to take significant personal and financial risks as an attorney-turned-entrepreneur.

    Scaling productionManufacturing partners & offshoring
    6 chapters

  • How I Built This · 1h 12m

    Beautycounter: Gregg Renfrew. She Built Beautycounter to $1B… Then Got Fired From Her Own Company

    Gregg Renfrew, founder of Beautycounter (now Counter), details her journey from selling Xerox machines to launching a direct-sales beauty brand that reached a $1B valuation. After being ousted by the Carlyle Group, she bought back the company's assets during foreclosure and rebuilt it as Counter, shifting to a commission-only affiliate model. Renfrew explains the technical challenges of formulating 'clean' beauty products without traditional ingredients and the strategic pivot away from team-based MLM structures to focus on brand integrity and safety standards.

    Direct-to-consumer & e-commerceMaterials & manufacturing processes
    7 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.